Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1950 3
1951 1
1952 3
1953 1
1954 2
1955 1
1957 2
1958 1
1959 3
1960 1
1962 1
1963 2
1965 2
1966 1
1969 3
1970 5
1971 2
1972 3
1973 1
1975 2
1976 1
1977 1
1979 1
1980 3
1982 1
1983 1
1985 2
1986 2
1987 2
1988 1
1989 2
1990 2
1992 2
1994 1
1995 2
1996 6
1997 2
1999 2
2000 3
2001 1
2002 1
2003 1
2004 5
2005 8
2006 6
2007 4
2008 4
2009 5
2010 1
2011 7
2012 7
2013 3
2014 5
2015 5
2016 8
2017 11
2018 5
2019 6
2020 4
2021 4
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Aphid BCR4 Structure and Activity Uncover a New Defensin Peptide Superfamily.
Loth K, Parisot N, Paquet F, Terrasson H, Sivignon C, Rahioui I, Ribeiro Lopes M, Gaget K, Duport G, Delmas AF, Aucagne V, Heddi A, Calevro F, da Silva P. Loth K, et al. Among authors: delmas af. Int J Mol Sci. 2022 Oct 18;23(20):12480. doi: 10.3390/ijms232012480. Int J Mol Sci. 2022. PMID: 36293341 Free PMC article.
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
Abreu MT, Davies JM, Quintero MA, Delmas A, Diaz S, Martinez CD, Venables T, Reich A, Crynen G, Deshpande AR, Kerman DH, Damas OM, Fernandez I, Santander AM, Pignac-Kobinger J, Burgueno JF, Sundrud MS. Abreu MT, et al. Among authors: delmas a. Inflamm Bowel Dis. 2022 Dec 1;28(12):1800-1812. doi: 10.1093/ibd/izac151. Inflamm Bowel Dis. 2022. PMID: 35993552 Free PMC article.
A synthetic kisspeptin analog that triggers ovulation and advances puberty.
Decourt C, Robert V, Anger K, Galibert M, Madinier JB, Liu X, Dardente H, Lomet D, Delmas AF, Caraty A, Herbison AE, Anderson GM, Aucagne V, Beltramo M. Decourt C, et al. Among authors: delmas af. Sci Rep. 2016 Jun 1;6:26908. doi: 10.1038/srep26908. Sci Rep. 2016. PMID: 27245315 Free PMC article.
179 results